Last month, Sanofi Pasteur, the vaccines division of Sanofi-Aventis, signed a marketing and distribution agreement with Emcure Pharmaceuticals for Verorab, its anti-rabies vaccine. Verorab is to be imported and supplied by Sanofi Pasteur India, while Emcure would market and distribute it. Sanofi-Aventis is setting up Asia's largest vaccine making facility in Hyderabad, for an investment of Rs 500 crore. It already enjoys a strong presence in the Indian vaccine space, following the buyout of Hyderabad-based Shantha Biotechnics in 2009 for Rs 3,000 crore.